The Perception of Cancer Risk in Patients with Barrett's Esophagus

巴雷特食管患者对癌症风险的认知

基本信息

  • 批准号:
    7260521
  • 负责人:
  • 金额:
    $ 14.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-07-15 至 2009-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Barrett's esophagus (BE), defined as the development of intestinal metaplasia in the esophagus, is a premalignant condition that predisposes to adenocarcinoma of the esophagus. The incidence of cancer in the setting of BE without dysplasia is low, approximating 0.005 cases/patient-year. We have previously demonstrated that patients with BE on average greatly overestimate their risk of development of cancer, and that over-estimation of risk was associated with a trend toward increased utilization of resources, such as endoscopy and clinic visits. The objectives of this application are: 1) to assess the perceived risk of esophageal adenocarcinoma in subjects with non-dysplastic BE in a multi-center study, 2) to assess the relationship between risk perception and the utilization of resources in these subjects, and, 3) to develop an internet-based based, self-directed teaching intervention to be administered to subjects with BE in a subsequent RO1 application. The investigators are experienced clinical researchers with a long record of investigation in BE, aided by experts in behavioral sciences. This planning grant would provide a mechanism to confirm observations from preliminary data regarding the overestimation of patients' cancer risk in the setting of Barrett's esophagus, and would examine the association between risk perception and healthcare utilization. It would also provide the means to develop an intervention designed to address patients' misunderstandings of risk, in the framework of a well-validated model of healthcare behavior. This grant will allow refining of disease definitions, outcome measures, sample size, and analysis plans and to address feasibility issues of a subsequent multi-center trial applying the intervention developed in this grant. The resultant study application will assess health-related quality of life, health-related anxiety and healthcare utilization as outcomes.
描述(由申请人提供): 巴雷特食管(BE),定义为食管肠上皮化生的发展,是一种易患食管腺癌的癌前病变。无异型增生BE患者的癌症发病率较低,约为0.005例/患者-年。我们以前已经证明,BE患者平均大大高估了他们患癌症的风险,并且风险的高估与资源利用增加的趋势有关,例如内窥镜检查和诊所就诊。本申请的目的是:1)在一项多中心研究中评估非异型增生BE受试者的食管腺癌感知风险,2)评估这些受试者的风险感知与资源利用之间的关系,3)开发一种基于互联网的自我指导教学干预措施,在随后的RO 1申请中对BE受试者进行管理。研究者是经验丰富的临床研究人员,在行为科学专家的帮助下,有着长期的BE研究记录。这项规划补助金将提供一种机制,以确认从初步数据中观察到的关于在巴雷特食管背景下高估患者癌症风险的结果,并将研究风险认知与医疗保健利用之间的关联。它还将提供一种手段,在一个经过充分验证的医疗保健行为模型的框架内,开发一种旨在解决患者对风险误解的干预措施。该补助金将允许细化疾病定义,结果测量,样本量和分析计划,并解决随后应用该补助金开发的干预措施的多中心试验的可行性问题。由此产生的研究应用程序将评估健康相关的生活质量,健康相关的焦虑和医疗保健利用作为结果。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Improving screening practices for Barrett's esophagus.
改善巴雷特食管的筛查实践。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NICHOLAS J SHAHEEN其他文献

NICHOLAS J SHAHEEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NICHOLAS J SHAHEEN', 18)}}的其他基金

Advanced a/LCI systems for improved clinical utility
先进的 a/LCI 系统可提高临床实用性
  • 批准号:
    9261900
  • 财政年份:
    2016
  • 资助金额:
    $ 14.8万
  • 项目类别:
Advanced a/LCI systems for improved clinical utility
先进的 a/LCI 系统可提高临床实用性
  • 批准号:
    10049233
  • 财政年份:
    2016
  • 资助金额:
    $ 14.8万
  • 项目类别:
Non-Endoscopic Surveillance for Barrett's Esophagus Following Ablative Therapy
消融治疗后巴雷特食管的非内镜监测
  • 批准号:
    9341252
  • 财政年份:
    2013
  • 资助金额:
    $ 14.8万
  • 项目类别:
Non-Endoscopic Surveillance for Barrett's Esophagus Following Ablative Therapy
消融治疗后巴雷特食管的非内镜监测
  • 批准号:
    9139436
  • 财政年份:
    2013
  • 资助金额:
    $ 14.8万
  • 项目类别:
Non-Endoscopic Surveillance for Barrett's Esophagus Following Ablative Therapy
消融治疗后巴雷特食管的非内镜监测
  • 批准号:
    8618302
  • 财政年份:
    2013
  • 资助金额:
    $ 14.8万
  • 项目类别:
Non-Endoscopic Surveillance for Barrett's Esophagus Following Ablative Therapy
消融治疗后巴雷特食管的非内镜监测
  • 批准号:
    8735947
  • 财政年份:
    2013
  • 资助金额:
    $ 14.8万
  • 项目类别:
Building a Better Neosquamous Barrier
建立更好的新鳞状细胞屏障
  • 批准号:
    8555514
  • 财政年份:
    2011
  • 资助金额:
    $ 14.8万
  • 项目类别:
Racial Disparity in Barrett's Esophagus
巴雷特食管的种族差异
  • 批准号:
    8068502
  • 财政年份:
    2010
  • 资助金额:
    $ 14.8万
  • 项目类别:
Perception of Cancer Risk in Patients with Barrett's
巴雷特氏症患者对癌症风险的认知
  • 批准号:
    7137036
  • 财政年份:
    2006
  • 资助金额:
    $ 14.8万
  • 项目类别:
Epidemiologic Case-control Study of Barrett's Esophagus
巴雷特食管流行病学病例对照研究
  • 批准号:
    6517872
  • 财政年份:
    2001
  • 资助金额:
    $ 14.8万
  • 项目类别:

相似国自然基金

大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
  • 批准号:
    30840003
  • 批准年份:
    2008
  • 资助金额:
    12.0 万元
  • 项目类别:
    专项基金项目

相似海外基金

Synergistic Radiosensitization of Hypoxic Pancreatic Adenocarcinoma using Gd-Texaphyrin Oxygen-Loaded Nanodroplets
使用 Gd-Texaphyrin 载氧纳米液滴对缺氧胰腺腺癌进行协同放射增敏
  • 批准号:
    478914
  • 财政年份:
    2023
  • 资助金额:
    $ 14.8万
  • 项目类别:
    Operating Grants
Expression mechanism of immune checkpoint molecules after carbon-ion radiotherapy in cervical adenocarcinoma specimens
宫颈腺癌碳离子放疗后免疫检查点分子的表达机制
  • 批准号:
    23K14913
  • 财政年份:
    2023
  • 资助金额:
    $ 14.8万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Study of fibrosis in pancreatic ductal adenocarcinoma (PDAC) and application of adipose-derived stromal/stem cells for PDAC treatment
胰腺导管腺癌(PDAC)纤维化的研究以及脂肪源性基质/干细胞在 PDAC 治疗中的应用
  • 批准号:
    23K15035
  • 财政年份:
    2023
  • 资助金额:
    $ 14.8万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
IRAK4 AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN PANCREATIC DUCTAL ADENOCARCINOMA
IRAK4 作为胰腺导管腺癌的新型免疫治疗靶点
  • 批准号:
    10442874
  • 财政年份:
    2023
  • 资助金额:
    $ 14.8万
  • 项目类别:
Therapeutic Targeting of NSD2 in Lung Adenocarcinoma
NSD2 在肺腺癌中的治疗靶向
  • 批准号:
    10657069
  • 财政年份:
    2023
  • 资助金额:
    $ 14.8万
  • 项目类别:
Control mechanisms of lung adenocarcinoma by SGLT2 inhibitors for treating diabetes mellitus.
SGLT2抑制剂治疗糖尿病对肺腺癌的控制机制。
  • 批准号:
    23K08326
  • 财政年份:
    2023
  • 资助金额:
    $ 14.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of histological transformation model from lung small cell carcinoma from adenocarcinoma to explore the therapeutic strategies of small cell lung carcinoma.
建立肺小细胞癌腺癌组织学转化模型,探讨小细胞肺癌的治疗策略。
  • 批准号:
    23K14614
  • 财政年份:
    2023
  • 资助金额:
    $ 14.8万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms of tumor progression controlled by tumor-initiating cells and cancer-associated fibroblasts in pancreatic adenocarcinoma.
阐明胰腺腺癌中肿瘤起始细胞和癌症相关成纤维细胞控制的肿瘤进展机制。
  • 批准号:
    23K15075
  • 财政年份:
    2023
  • 资助金额:
    $ 14.8万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular mechanisms for development of pulmonary invasive mucinous adenocarcinoma
肺浸润性粘液腺癌发生的分子机制
  • 批准号:
    23H02698
  • 财政年份:
    2023
  • 资助金额:
    $ 14.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidating the Cellular Origins of lung adenocarcinoma
阐明肺腺癌的细胞起源
  • 批准号:
    10743611
  • 财政年份:
    2023
  • 资助金额:
    $ 14.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了